Search
Search Results
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, December 2014
- Subject(s):
- Comparative Effectiveness Research
Diabetes Mellitus, Type 2 -- drug therapy
Disease Management
Blood Glucose -- analysis
Blood Glucose -- metabolism
Dipeptidyl-Peptidase IV Inhibitors -- therapeutic use
Drug Therapy, Combination
Hemoglobin A, Glycosylated -- analysis
Hypoglycemic Agents -- administration & dosage
Hypoglycemic Agents -- therapeutic use
Insulin -- therapeutic use
Metformin -- administration & dosage
Metformin -- therapeutic use
Monitoring, Ambulatory
Randomized Controlled Trials as Topic
Receptors, Glucagon -- agonists
Sulfonylurea Compounds -- administration & dosage
Sulfonylurea Compounds -- therapeutic use
Treatment Outcome
Humans
New England
United States
- Author(s):
- Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Chapman, Rick, author
Shore, Karen K., author
Weissberg, Jed, author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, March 14, 2016
- Subject(s):
- Blood Glucose -- drug effects
Diabetes Mellitus, Type 1 -- drug therapy
Diabetes Mellitus, Type 2 -- drug therapy
Hypoglycemia -- prevention & control
Hypoglycemic Agents -- therapeutic use
Insulin, Long-Acting -- administration & dosage
Insulin, Long-Acting -- therapeutic use
Blood Glucose -- metabolism
Cost-Benefit Analysis
Diabetes Mellitus, Type 1 -- blood
Diabetes Mellitus, Type 1 -- complications
Diabetes Mellitus, Type 2 -- blood
Diabetes Mellitus, Type 2 -- complications
Hypoglycemia -- blood
Hypoglycemia -- chemically induced
Hypoglycemic Agents -- administration & dosage
Insulin -- adverse effects
Severity of Illness Index
Humans
United States
- Author(s):
- Lin, Grace A., author
Nikitin, Dmitriy, author
Moradi, Ashton, author
Herron-Smith, Serina, author
Pearson, Steven D., author
Campbell, Jon D., author
Brouwer, Elizabeth, author
Chen, Yilin, MPH, author
Hansen, Ryan N., author
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, February 15, 2022
- Subject(s):
- Diabetes Mellitus, Type 2 -- drug therapy
Gastric Inhibitory Polypeptide -- therapeutic use
Hypoglycemic Agents -- therapeutic use
Incretins -- therapeutic use
United States